Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2986880 | 1.00 | USP2 (0.36) | USP2NPSR1 | |
| SCHEMBL2986881 | 1.00 | USP2 (0.36) | USP2NPSR1 | |
| SCHEMBL1783918 | 1.00 | USP2 (0.36) | USP2NPSR1 | |
| SCHEMBL8462040 | 0.87 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL21964082 | 0.78 | F10 (0.35) | USP2NPSR1 | |
| SCHEMBL28581142 | 0.78 | USP2 (0.32) | USP2NPSR1 | |
| SCHEMBL7784061 | 0.78 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL12611338 | 0.78 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL7784007 | 0.74 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL13206360 | 0.73 | USP2 (0.40) | USP2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8450533-B2 | Cyclopropanation process | GIVAUDAN SA (CH) | 2013-05-28 | — | — | US | disclosed |
| US-20110124924-A1 | Cyclopropanation Process | GIVAUDAN SA (CH) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124924-A1 | Cyclopropanation Process | CBR3, CYP4F3, DBF4 | USP2 2581/4885NPSR1 4224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.